A/Prof Peter Meikle is Head of the Metabolomics Laboratory at Baker IDI Heart and Diabetes Institute and a NHMRC Senior Research Fellow. He holds affiliate positions at Bio21, Melbourne University and the Department of Medicine, Monash University. The Metabolomics Laboratory has a focus on the dyslipidaemia associated with obesity, diabetes and cardiovascular disease and its relationship to the pathogenesis of these disease states. The work is leading to new approaches to early diagnosis, risk assessment and therapeutic monitoring of these most prevalent diseases.
Abstracts this author is presenting: